{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:08:21Z","timestamp":1789394901132,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Insulin resistance (IR) is a key driver of type 2 diabetes mellitus (T2DM) onset, and diabetic microvascular complications (DMC) represent its poor prognosis. However, simple and non-invasive screening methods for detection of IR and DMC are limited. The urinary C-peptide\/creatinine ratio (UCPCR) can be used to measure \u03b2-cell function, and we aimed to evaluate its utility as a surrogate marker for IR in non-diabetic individuals and for DMC risk in patients with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study enrolled 447 individuals (255 non-diabetic adults and 192 T2DM patients) from November 2023 to September 2025. The non-diabetic cohort was divided into IR and non-IR groups according to the Matsuda index. The diabetic cohort was divided into DMC and non-DMC groups. Fasting UCPCR (0hUCPCR) and 2-h post-OGTT\/steamed bread meal (2hUCPCR) were measured. Multiple regression analysis was used to describe the association between UCPCR and the Matsuda index or DMC. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the non-diabetic individuals, both 0hUCPCR and 2hUCPCR were higher in the IR group, and they were negatively associated with the Matsuda index (\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.488,\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.636) (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) by Spearman\u2019s correlation analysis. Multiple linear regression analysis demonstrated that 0hUCPCR (\n                      <jats:italic>B<\/jats:italic>\n                      = \u22120.351) and 2hUCPCR (\n                      <jats:italic>B<\/jats:italic>\n                      = \u22120.162) were negatively associated with the Matsuda index (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). ROC analysis revealed that the areas under the curve (AUC) for screening IR were 0.780 and 0.831, with corresponding sensitivities of 64.4% and 77.6%, respectively. In the T2DM patients, 0hUCPCR and 2hUCPCR were lower in the DMC group, and they showed positive correlations with HOMA-\u03b2 (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.582,\n                      <jats:italic>r<\/jats:italic>\n                      = 0.617) (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Multivariable logistic regression analysis demonstrated that 2hUCPCR was negatively associated with DMC (OR = 0.627,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.030). ROC analysis revealed that 2hUCPCR predicted DMC risk with an AUC of 0.751 and a sensitivity of 70.7%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both 0hUCPCR and 2hUCPCR are promising markers for IR in non-diabetic adults, and 2hUCPCR is associated with lower risk of DMC in T2DM patients. Coupled with their practical advantages of simplicity and non-invasiveness, UCPCRs are promising tools for future large-scale screening in at-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1786731","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:22:42Z","timestamp":1773897762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The dual role of urinary C-peptide\/creatinine ratio: predicting insulin resistance in non-diabetic adults and microvascular complications risk in patients with type 2 diabetes"],"prefix":"10.3389","volume":"17","author":[{"given":"Shufen","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"13","author":"Genitsaridi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102581","article-title":"Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride\/glucose index","volume":"16","author":"Tahapary","year":"2022","journal-title":"Diabetes Metab Syndrome"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae540","article-title":"Pre-prediabetes: insulin resistance is associated with cardiometabolic risk in nonobese patients (STOP DIABETES)","volume":"110","author":"Armato","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1674-5809.2018.06.001","article-title":"Expert guidance on methods and applications for the assessment of insulin resistance","volume":"10","year":"2018","journal-title":"Chin J Diabetes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01200-7","article-title":"Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications","volume":"20","author":"Sun","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221146808","article-title":"Short-term glycemic variability and its association with macrovascular and microvascular complications in patients with diabetes","volume":"18","author":"Psoma","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e002720","DOI":"10.1136\/bmjdrc-2021-002720","article-title":"Prevalence of long-term complications in inpatients with diabetes mellitus in China: a nationwide tertiary hospital-based study","volume":"10","author":"Liu","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5064","article-title":"Diabetic foot","volume":"359","author":"Mishra","year":"2017","journal-title":"BMJ (Clin Res ed)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30411-5","article-title":"Screening for diabetic retinopathy: new perspectives and challenges","volume":"8","author":"Vujosevic","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B14","article-title":"Expert consensus on screening and prevention of primary diabetic microvascular disease (2024)","volume":"27","author":"Zilin","year":"2024","journal-title":"Chin Family Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn115791-20220104-00005","article-title":"Clinical expert consensus on the assessment and protection of pancreatic \u03b2-cell function in type 2 diabetes mellitus","volume":"14","year":"2022","journal-title":"Chin J Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/000456329903600501","article-title":"Assays for insulin, proinsulin(s) and C-peptide","volume":"36","author":"Clark","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.129312","article-title":"Stability and reproducibility of a single-sample urinary C-peptide\/creatinine ratio and its correlation with 24-h urinary C-peptide","volume":"55","author":"McDonald","year":"2009","journal-title":"Clin Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1052794","article-title":"Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/nu15092073","article-title":"Urinary C-peptide to creatinine ratio (UCPCR) as indicator for metabolic risk in apparently healthy adults-A bioPersMed cohort study","volume":"15","author":"Reintar","year":"2023","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01847-2","article-title":"Urinary C-peptide and urinary C-peptide creatinine ratio as markers for insulin resistance in obese children and adolescents","volume":"92","author":"Hassan","year":"2022","journal-title":"Pediatr Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1747684","article-title":"Clinical implications of urinary C-peptide creatinine ratio in patients with different types of diabetes","volume":"2019","author":"Wang","year":"2019","journal-title":"J Diabetes Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0623","article-title":"Routine islet autoantibody testing in clinically diagnosed adult-onset type 1 diabetes can help identify misclassification and the possibility of successful insulin cessation","volume":"45","author":"Eason","year":"2022","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.866107","article-title":"Stimulated UCPCR levels are lower in people with type 1 diabetes than in other diabetes types in sub-saharan africa: results from a preliminary cross-sectional study","volume":"10","author":"Katte","year":"2022","journal-title":"Front Public Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0538","article-title":"Neprilysin inhibitor may increase urinary C-peptide excretion","volume":"45","author":"Nishiya","year":"2022","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12056","article-title":"Distribution of the Matsuda Index in Japanese healthy subjects","volume":"4","author":"Takahara","year":"2013","journal-title":"J Diabetes Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn311282-20210304-00142","article-title":"Guidelines for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)","volume":"37","year":"2021","journal-title":"Chin J Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals","volume":"15","author":"Andersson","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110602","article-title":"Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China","volume":"198","author":"Li","year":"2023","journal-title":"Diabetes Res Clin Practice"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e003193","DOI":"10.1136\/bmjopen-2013-003193","article-title":"Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study","volume":"3","author":"Oram","year":"2013","journal-title":"BMJ Open"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-6187.2023.10.009","article-title":"Applied value of urinary C-peptide\/creatinine for assessing residual islet function and risk of complications in type 1 diabetes mellitus","volume":"31","author":"Qiao","year":"2023","journal-title":"Chin J Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/1753-0407.13203","article-title":"Urinary C-peptide\/creatinine ratio: A useful biomarker of insulin resistance and refined classification of type 2 diabetes mellitus","volume":"13","author":"Wang","year":"2021","journal-title":"J Diabetes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/joim.12541","article-title":"C-peptide and the pathophysiology of microvascular complications of diabetes","volume":"281","author":"Wahren","year":"2017","journal-title":"J Internal Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12916-023-02760-7","article-title":"Simultaneous attenuation of hyperglycemic memory-induced retinal, pulmonary, and glomerular dysfunctions by proinsulin C-peptide in diabetes","volume":"21","author":"Jeon","year":"2023","journal-title":"BMC Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7150\/thno.81714","article-title":"Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy","volume":"13","author":"Moon","year":"2023","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0293","article-title":"C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e003201","DOI":"10.1136\/bmjdrc-2022-003201","article-title":"High levels of serum C-peptide are associated with a decreased risk for incident renal progression in patients with type 2 diabetes: a retrospective cohort study","volume":"11","author":"Qi","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"102725","DOI":"10.1016\/j.dsx.2023.102725","article-title":"Association of C-peptide level with peripheral neuropathy in type 2 diabetes: An observational cross-sectional preliminary study","volume":"17","author":"Umaid","year":"2023","journal-title":"Diabetes Metab Syndr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2008.00952.x","article-title":"The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes","volume":"10","author":"G","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"151240","DOI":"10.1016\/j.ejcb.2022.151240","article-title":"Amino acids control blood glucose levels through mTOR signaling","volume":"101","author":"Jialin","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"116811","DOI":"10.1016\/j.celrep.2025.116811","article-title":"PDX1 phosphorylation at S61 by mTORC1 links nutrient signaling to \u03b2 cell function and metabolic disease","volume":"45","author":"Jialin","year":"2026","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"108830","DOI":"10.1016\/j.celrep.2021.108830","article-title":"Amino acids-Rab1A-mTORC1 signaling controls whole-body glucose homeostasis","volume":"34","author":"Xin","year":"2021","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/cells13090781","article-title":"Nuclear mTOR signaling orchestrates transcriptional programs underlying cellular growth and metabolism","volume":"13","author":"Tinghan","year":"2024","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/s41598-021-82053-2","article-title":"Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s13098-025-01920-4","article-title":"AI-driven prediction of insulin resistance in non-diabetic populations using minimal invasive tests: comparing models and criteria","volume":"17","author":"Gao","year":"2025","journal-title":"Diabetol Metab Syndrome"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2039956","article-title":"Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China","volume":"54","author":"Huang","year":"2022","journal-title":"Ann Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1373039","article-title":"Triglyceride glucose-related indexes and lipid accumulation products-reliable markers of insulin resistance in the Chinese population","volume":"11","author":"Liu","year":"2024","journal-title":"Front  Nutr"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1541663","article-title":"Predict and prevent microvascular complications of type 2 diabetes: a cross-sectional and longitudinal study in Chinese communities","volume":"16","author":"Liu","year":"2025","journal-title":"Front  Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/ijms17050744","article-title":"Postprandial C-peptide to glucose ratio as a marker of \u03b2 Cell function: implication for the management of type 2 diabetes","volume":"17","author":"Saisho","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.07.024","article-title":"Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test","volume":"60","author":"Martinez-Hervas","year":"2010","journal-title":"Metabol: Clin Experimental"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i9.109414","article-title":"Postprandial C-peptide is more relevant to hemoglobin A1c levels and diabetic microvascular complications than fasting C-peptide in type 2 diabetes","volume":"16","author":"Wang","year":"2025","journal-title":"World J Diabetes"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15595","article-title":"C-peptide index at 2\u2009h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes","volume":"26","author":"Iwamoto","year":"2024","journal-title":"Diabetes Obes Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1786731\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:22:48Z","timestamp":1773897768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1786731\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":52,"alternative-id":["10.3389\/fendo.2026.1786731"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1786731","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"1786731"}}